AVALO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
AVALO THERAPEUTICS, INC. (AVTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $3.93 per share as of 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2018-04-02
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.93.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.41.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $4.76.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.06.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2017-12-31 | $3.93 10-K · filed 2018-04-02 |
| 2017-09-30 | $4.41 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.76 10-Q · filed 2017-08-14 |
| 2017-03-31 | $5.06 10-Q · filed 2017-05-09 |
| 2016-12-31 | $5.57 10-K · filed 2018-04-02 |
| 2016-09-30 | $5.68 10-Q · filed 2016-11-08 |
| 2016-06-30 | $6.05 10-Q · filed 2016-08-15 |
| 2016-03-31 | $6.19 10-Q · filed 2016-05-16 |
| 2015-12-31 | $7.68 10-K · filed 2018-04-02 |
| 2015-09-30 | $8.88 10-Q · filed 2015-11-13 |
| 2014-12-31 | $9.17 10-K · filed 2017-03-14 |
| 2013-12-31 | $7.78 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |